Onxeo SA Financials
| C4X Stock | EUR 0.07 0.0001 0.14% |
Onxeo |
Understanding current and past Onxeo SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Onxeo SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Onxeo SA's assets may result in an increase in income on the income statement.
Onxeo SA Stock Summary
Onxeo SA competes with Spirent Communications, Compagnie Plastic, Rayonier Advanced, Mobilezone Holding, and SBA Communications. Onxeo SA, a clinical-stage biotechnology company, designs and develops oncology drugs for tumor DNA repair functions worldwide. Onxeo SA was incorporated in 1997 and is headquartered in Paris, France. ONXEO S operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 29 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | FR0010095596 |
| Business Address | 49, boulevard du |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.onxeo.com |
| Phone | 33 1 45 58 76 00 |
| Currency | EUR - Euro |
You should never invest in Onxeo SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Onxeo Stock, because this is throwing your money away. Analyzing the key information contained in Onxeo SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Onxeo SA Key Financial Ratios
There are many critical financial ratios that Onxeo SA's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Onxeo SA reports annually and quarterly.Onxeo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Onxeo SA's current stock value. Our valuation model uses many indicators to compare Onxeo SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Onxeo SA competition to find correlations between indicators driving Onxeo SA's intrinsic value. More Info.Onxeo SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Onxeo SA's earnings, one of the primary drivers of an investment's value.Onxeo SA Systematic Risk
Onxeo SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Onxeo SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Onxeo SA correlated with the market. If Beta is less than 0 Onxeo SA generally moves in the opposite direction as compared to the market. If Onxeo SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Onxeo SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Onxeo SA is generally in the same direction as the market. If Beta > 1 Onxeo SA moves generally in the same direction as, but more than the movement of the benchmark.
Onxeo SA December 13, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Onxeo SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Onxeo SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Onxeo SA based on widely used predictive technical indicators. In general, we focus on analyzing Onxeo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Onxeo SA's daily price indicators and compare them against related drivers.
| Downside Deviation | 8.78 | |||
| Information Ratio | 0.0191 | |||
| Maximum Drawdown | 65.03 | |||
| Value At Risk | (12.59) | |||
| Potential Upside | 14.8 |
Complementary Tools for Onxeo Stock analysis
When running Onxeo SA's price analysis, check to measure Onxeo SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Onxeo SA is operating at the current time. Most of Onxeo SA's value examination focuses on studying past and present price action to predict the probability of Onxeo SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Onxeo SA's price. Additionally, you may evaluate how the addition of Onxeo SA to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |